Navigation Links
Use of antidepressant does not improve symptoms from stomach disorder
Date:12/24/2013

Among patients with idiopathic (of unknown cause) gastroparesis, use of the antidepressant nortriptyline compared with placebo for 15 weeks did not result in improvement in overall symptoms, according to a study appearing in the December 25 issue of JAMA. Gastroparesis is a disease of the muscles of the stomach or the nerves controlling the muscles that causes the muscles to stop working, which can result in inadequate grinding of food by the stomach and poor emptying of food from the stomach into the intestine.

Gastroparesis remains a challenging syndrome to manage, with few effective treatments and a lack of rigorously controlled trials. One possible approach to treatment is based on the hypothesis that some of the symptoms (e.g., nausea, pain) arise because of changes in certain nerves. Tricyclic antidepressants are a category of drug often used to treat refractory (not yielding readily to treatment) symptoms of nausea, vomiting, and abdominal pain, according to background information in the article.

Henry P. Parkman, M.D., of Temple University, Philadelphia, and colleagues randomized 130 patients with idiopathic gastroparesis to nortriptyline (n = 65) or placebo (n = 65) to determine whether treatment with the tricyclic antidepressant nortriptyline would result in improvement of symptoms. Study drug dose was increased at 3-week intervals. The primary outcome measure was a decrease in the patient's Gastroparesis Cardinal Symptom Index (GCSI) score of at least 50 percent on 2 consecutive visits during 15 weeks of treatment.

The researchers found that the proportion of patients experiencing symptomatic improvement on 2 visits did not differ between the treatment groups: 15 (23 percent) in the nortriptyline group vs. 14 (21 percent) in the placebo group. There were also no treatment group differences in measures of nausea, fullness or early satiety, or bloating. Treatment was stopped more often in the nortriptyline group (29 percent) than in the placebo group (9 percent), but numbers of adverse events were not different.

"Our results raise general doubts about the utility of tricyclic antidepressants in low doses as a strategy for the treatment of idiopathic gastroparesis," the authors conclude.


'/>"/>

Contact: Kathleen Duffy
Kathleen.Duffy@tuhs.temple.edu
267-800-4359
The JAMA Network Journals
Source:Eurekalert

Related medicine news :

1. Minorities, Medicare Recipients Less Likely to Get Antidepressants
2. Newer Antidepressants May Be Safe for Parkinsons Patients
3. Publication Bias Casts Doubt on Value of Antidepressants for Autism
4. Antidepressant use associated with increased mortality among critically ill patients?
5. Medicare Coverage Gap May Cause Seniors to Forgo Antidepressants
6. Mayo Clinic: Antidepressant eases radiation-related mouth pain in head, neck cancer
7. Common Antidepressants Too Risky During Pregnancy, Researchers Say
8. Common Antidepressants Tied to Higher Bleeding Risk in Warfarin Users: Study
9. When Antidepressants Dont Work, Give Counseling a Try
10. Experimental Antidepressant Appears Quick-Acting, Safe
11. Study shows antidepressant could do double duty as diabetes drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2019)... ... August 21, 2019 , ... Photoprotective Technologies (PPT) has just received ... ingredient is currently used in skincare products such as creams or makeup and is ... the growing need to protect the skin from blue light as well as UV. ...
(Date:8/19/2019)... (PRWEB) , ... August 19, 2019 , ... ... filling and secondary packaging needs, announced the availability of resealable single-dose vials for ... Division of the Guala Group, consists of five resealable breakaway vials and are ...
(Date:8/19/2019)... ... 19, 2019 , ... Professional Enrollment Concepts (PEC), a top ... they have ranked #3056 on the 2019 Inc. 5000 Fastest-Growing Private Companies list. ... the most successful companies within the American economy's most dynamic segment—its independent small ...
(Date:8/17/2019)... ... August 17, 2019 , ... Approximately ... dental care services today under a program sponsored by United Concordia Dental and ... proud to work alongside them to make these services available to area youths ...
(Date:8/16/2019)... ... ... The clinical trial supply chain landscape is constantly shifting, and clinical professionals are ... Manufacturing Solutions Manager at Almac Clinical Services , Natalie Balanovsky, in a ... a journey through time as it relates to clinical trial supply. , She ...
Breaking Medicine News(10 mins):
(Date:8/19/2019)... ... August 19, 2019 , ... Physician Partners of ... join its Richardson, Texas location, starting Monday, Sep. 2nd. , Dr. Spiro Khoury ... subspecialty board certification in pain management. , Dr. Khoury attended the American University ...
(Date:8/17/2019)... ... ... The American Legion Dorchester Post 91 in Cambridge, Md., donated another $16,000 in ... veteran patients, adding to a donation in the same amount it made to the ... from Post 91 will enable the VA Maryland Health Care System to purchase a ...
(Date:8/16/2019)... ... August 16, 2019 , ... A ... approval, providing an alternative that both corrects the curve and maintains flexibility in ... methods and techniques developed by medical staff of Shriners Hospitals for Children® — ...
Breaking Medicine Technology: